Multicultural Centre for Women's Health is hosting Advancing the Evidence, a national conference on migrant and refugee women's health and wellbeing on 27-28 February 2020.
The conference will bring together researchers, general practitioners, clinical and community practitioners, policy makers and advocates from across Australia for two incredible days of collaboration, engaging discussion and interactive knowledge exchange.
It will focus on the sexual and reproductive health and rights of all women living in Australia from migrant and refugee backgrounds, including:
- health equity issues in policy and service delivery,
- national and international health policy,
- findings that build the current evidence base for migrant women's health migrant,
- broader social and systemic factors impacting migrant and refugee women’s health,
- connections between migrant and refugee women’s sexual and reproductive health and violence against women, mental health and work-related health.
Free entry to cocktail reception - Day One, 27 February 6pm
All conference delegates will receive free admission to a cocktail reception for the launch of the national campaign to end Female Genital Mutilation/Cutting (FGM/C).
The campaign will work with practitioners, who play a vital role in improving migrant women's sexual and reproductive health, to help end FGM/C.
Ticket prices for non-conference delegates are $88 here.
Date: 27 & 28 February 2020
Venue: Novotel Melbourne on Collins, 270 Collins St, Melbourne VIC 3000, Australia
Is there a discount for conference accommodation?
Conference delegates can book accommodation at the Novotel on Collins for a discounted rate. Contact us to make a booking.
Are there conference scholarships available?
A limited number of conference scholarships are available for low to no income earners. Contact us for more information.
Dr Alice Han
Dr Han is a Canadian obstetrician and gynaecologist with a global health background. Her research focuses on the intersection of violence against women (VAW), reproductive health outcomes and health system response. She has worked in Brazil with a World Health Organization Collaborating Centre, in rural Rwanda with Partners in Health, and as Instructor at Harvard Medical School on the equitable provision of health. Her clinical, public health, and research training sites have included Kenya, Israel, Palestine, Azerbaijan, Philippines, Vietnam, Greece, and Ecuador.
She advocates for improved health system response to VAW through her TEDx talk, was a technical reviewer for the WHO-UNHCR-UNFPA Clinical Management of Rape Survivors, and was an invited facilitator for an international WHO training workshop in Geneva on Health Response to VAW. She has co-authored a chapter on “Health and Human Rights Through Development” in the forthcoming Oxford University Press volume on Foundations of Global Health & Human Rights, and has lectured to law students at a Harvard T.H.Chan School of Public Health / O.P. Jindal Global University Summer School on Human Rights and Development. (Photo by Matthew Guillory)
Dr Jasmine Abdulcadir
Jasmine Abdulcadir, MD PD FECSM, an obstetrician/gynaecologist and founder of the outpatient clinic for women and girls living with Female Genital Mutilation/Cutting, Geneva University Hospitals. She is one of the four members of the international "G3" network on FGM/C and in 2018, and was awarded a knighthood from the Italian Republic for her work in fighting and treating the complications of FGM/C.
Jasmine Abdulcadir teaches at the University of Geneva, Midwife school of Vaud, Lausanne and at national and international training courses for healthcare professionals working with women and girls with FGM/C. She has worked as a consultant for the Department of Reproductive Health and Research, Adolescents and at-risk populations team, World Health Organization (WHO), Swiss Network and Swiss Migration Secretary on FGM/C issues. Her research has been published in several scientific articles and chapters on the improvement of the reproductive and sexual health of women with FGM/C.